News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.66d agoneutral
Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. PatientsSimply Wall St.67d agoneutral
Biogen (BIIB) Stock Could Be 48% Below Fair Value On New Dravet DataInsider Monkey70d agoneutral
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock PicksMT Newswires75d agobullish
Veeva's Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist SaysSimply Wall St.79d agoneutral
Is Biogen (BIIB) Undervalued On Raised EPS Guidance And Key Phase 3 Readouts?Simply Wall St.79d agoneutral
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For ShareholdersMarketBeat83d agoneutral
Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero DropoutsInvesting.com87d agobullish
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuationInvestor's Business Daily95d agoneutral
Biogen Stock: How To Find & Own America's Greatest OpportunitiesStockStory99d agobullish
BIIB Q2 Deep Dive: Portfolio Expansion and Pipeline Readouts Drive Upbeat OutlookSimply Wall St.101d agoneutral
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth - Is Profitability Peaking?GuruFocus.com102d agoneutral
Biogen Inc (BIIB) Q2 2026 Earnings Call Highlights: Strong Growth in Core Pharmaceuticals and ...